Prior corticosteroid treatment alters cPBMC composition and IFNγ response to immunotherapy in canine cancer.

Zimmermann ABE, Taskoparan B, Fuchs D, Pantelyushin S, Maheswaran M, Schnyder M, Hartnack S, Rohrer Bley C, Vom Berg J

Open source

DOI: 10.3389/fimmu.2025.1544949
Published: 2025
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2025.1544949,
  title = {Prior corticosteroid treatment alters cPBMC composition and IFNγ response to immunotherapy in canine cancer.},
  author = {Zimmermann ABE and Taskoparan B and Fuchs D and Pantelyushin S and Maheswaran M and Schnyder M and Hartnack S and Rohrer Bley C and Vom Berg J},
  year = {2025},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2025.1544949},
  url = {https://doi.org/10.3389/fimmu.2025.1544949}
}

RIS

TY  - JOUR
TI  - Prior corticosteroid treatment alters cPBMC composition and IFNγ response to immunotherapy in canine cancer.
AU  - Zimmermann ABE
AU  - Taskoparan B
AU  - Fuchs D
AU  - Pantelyushin S
AU  - Maheswaran M
AU  - Schnyder M
AU  - Hartnack S
AU  - Rohrer Bley C
AU  - Vom Berg J
PY  - 2025
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2025.1544949
UR  - https://doi.org/10.3389/fimmu.2025.1544949
ER  -

APA

ABE, Z., B, T., D, F., S, P., M, M., M, S., S, H., C, R. B., & J, V. B. (2025). Prior corticosteroid treatment alters cPBMC composition and IFNγ response to immunotherapy in canine cancer.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2025.1544949

Source records

pubmed · retrieved 2026-11-10T12:01:57.204Z
europe-pmc · retrieved 2026-11-10T12:01:57.208Z
doaj · retrieved 2026-11-10T12:01:57.204Z